|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
SG44845A1
(en)
|
1993-01-12 |
1997-12-19 |
Biogen Inc |
Recombitant anti-vla4 antibody molecules
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
US5622861A
(en)
|
1994-08-05 |
1997-04-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant DNA encoding hepatitis A virus receptor
|
|
US6066322A
(en)
*
|
1995-03-03 |
2000-05-23 |
Millennium Pharmaceuticals, Inc. |
Methods for the treatment of immune disorders
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
DE19541844C1
(de)
|
1995-11-09 |
1997-07-24 |
Gsf Forschungszentrum Umwelt |
Verfahren zur Herstellung von menschlichen Antikörpern und deren Verwendung
|
|
US6165733A
(en)
|
1996-05-23 |
2000-12-26 |
Chiron Corporation |
γ II adaptin
|
|
JP4602482B2
(ja)
*
|
1996-05-24 |
2010-12-22 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
組織再生のモジュレーター
|
|
JP2001503271A
(ja)
|
1996-11-01 |
2001-03-13 |
ヒューマン ジノーム サイエンシーズ，インコーポレイテッド |
ヒト粘膜アドレシン細胞接着分子―１（ＭＡｄＣＡＭ―１）およびそのスプライス変異体
|
|
EP1972194A1
(en)
|
1996-12-03 |
2008-09-24 |
Amgen Fremont Inc. |
Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
|
|
JP4094066B2
(ja)
|
1996-12-06 |
2008-06-04 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
インターロイキン−１β変換酵素のインヒビター
|
|
KR100764256B1
(ko)
|
1998-01-23 |
2007-10-05 |
에프. 호프만-라 로슈 아게 |
인간 인터루킨-12에 대한 항체
|
|
CN1160075C
(zh)
|
1998-03-11 |
2004-08-04 |
卫福有限公司 |
杂环酰胺化合物在制备IgE抗体产生抑制剂中的用途
|
|
US6228642B1
(en)
|
1998-10-05 |
2001-05-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression
|
|
US8288322B2
(en)
|
2000-04-17 |
2012-10-16 |
Dyax Corp. |
Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
|
|
JP2004500879A
(ja)
*
|
2000-06-16 |
2004-01-15 |
バイオジェン インコーポレイテッド |
腎の調節エレメントおよびそれらの使用方法
|
|
DK1401869T3
(da)
*
|
2001-06-01 |
2008-04-28 |
Biogen Idec Inc |
Molekyler og fremgangsmåder til inhibering af udskillkelse af kim 1
|
|
JP4572276B2
(ja)
*
|
2001-06-29 |
2010-11-04 |
ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニヴァーシティ |
Ｔ細胞調節遺伝子およびその使用方法
|
|
US7838220B2
(en)
*
|
2001-06-29 |
2010-11-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
T cell regulatory genes associated with immune disease
|
|
CA2459219A1
(en)
|
2001-09-17 |
2003-03-27 |
Protein Design Labs, Inc. |
Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
|
|
WO2003042661A2
(en)
|
2001-11-13 |
2003-05-22 |
Protein Design Labs, Inc. |
Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
|
|
US7687454B2
(en)
*
|
2001-12-03 |
2010-03-30 |
The University Of British Columbia |
Effectors of innate immunity determination
|
|
JP4694128B2
(ja)
*
|
2002-01-30 |
2011-06-08 |
ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド |
ＴＩＭ−３、Ｔｈ１特異的細胞表面分子に関連した組成物および方法
|
|
AU2003228336B2
(en)
*
|
2002-03-19 |
2009-07-30 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
GB0215509D0
(en)
|
2002-07-04 |
2002-08-14 |
Novartis Ag |
Marker genes
|
|
CA2512138C
(en)
*
|
2002-12-30 |
2013-07-16 |
Biogen Idec Ma Inc. |
Kim-1 antagonists and use to modulate immune system
|
|
CA2519528C
(en)
|
2003-03-19 |
2016-01-26 |
Abgenix, Inc. |
Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
|
|
US20050119210A1
(en)
|
2003-05-20 |
2005-06-02 |
Xiaobing Be |
Compositions and methods for diagnosing and treating cancers
|
|
TW200539890A
(en)
*
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
|
BRPI0509139A
(pt)
*
|
2004-03-24 |
2007-08-28 |
Telos Fharmaceuticals Inc |
composição, e, método de estimulação de uma resposta imune em um indivìduo, de tratamento profilático de uma doença, de melhoramento de um sinal ou sintoma associado com uma doença, de alvejamento de um tumor, de inibição do crescimento de tumor, e de detecção de um tumor
|
|
US8025557B2
(en)
|
2009-02-27 |
2011-09-27 |
Illinois Tool Works Inc. |
Sanding clay
|